Brazilian investors may find opportunities to reduce portfolio volatility tied to the domestic economy through time-tested, multi-sector business models. This basket provides exposure to a selection of large-cap, US-listed conglomerates with diversified global operations.
Published on October 20
These conglomerates offer natural protection against economic downturns by spreading risk across multiple industries and geographic regions. When one sector struggles, others can provide stability.
Access to worldwide markets means these companies aren't dependent on any single economy. For Brazilian investors, this provides valuable currency diversification and exposure to developed markets.
These blue-chip companies have weathered multiple economic cycles and proven their resilience. Many follow Warren Buffett's investment principles, focusing on sustainable competitive advantages and long-term value creation.
These US conglomerates offer Brazilian investors a strategic way to reduce dependence on domestic economic cycles and commodity volatility. By investing in multi-sector businesses with global operations, you can access more stable, diversified revenue streams that aren't tied to any single industry or geographic region.
This group features large-cap, blue-chip companies that operate across multiple industriesโfrom manufacturing and aerospace to consumer goods and finance. These established firms have proven track records and global revenue streams, providing both currency and geographic diversification for your portfolio.
Each company was selected for its diversified business model and time-tested approach to value creation. These conglomerates and holding companies represent Warren Buffett-style investing principles, offering Brazilian investors access to resilient, multi-sector enterprises with consistent long-term growth potential.
Summary and investor key takeaways for the provided basket market capitalisation data.
PG: $354.35B
KO: $294.54B
MMM: $81.30B
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
+2
Here are a few of the assets in this group. Create an account to unlock the full list.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+12.28%
On average, analysts expect assets in this group to grow 12.28% over the next year.
9 of 12 assets in this group are rated Buy by professional analysts.
